SIM
GYRE icon

Spark Investment Management’s Gyre Therapeutics GYRE Stock Holding History

Spark Investment Management’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,707
Closed -$94K – 440
2019
Q2 		$94K Buy
+1,707
New +$107K 0.01% 505
2018
Q3 		– Sell
-5,227
Closed -$457K – 689
2018
Q2 		$457K Buy
5,227
+3,520
+206% +$617K 0.03% 450
2018
Q1 		$330K Buy
+1,707
New +$318K 0.02% 450
2016
Q2 		– Sell
-170
Closed -$32K – 811
2016
Q1 		$32K Sell
170
-58
-25% -$14K ﹤0.01% 751
2015
Q4 		$80K Buy
228
+48
+27% +$18.9K 0.01% 678
2015
Q3 		$94K Buy
180
+96
+114% +$146K 0.01% 611
2015
Q2 		$181K Sell
84
-4
-5% -$8.02K 0.03% 542
2015
Q1 		$204K Sell
88
-41
-32% -$84.7K 0.03% 547
2014
Q4 		$266K Buy
129
+33
+34% +$63.6K 0.04% 442
2014
Q3 		$189K Buy
+96
New +$237K 0.03% 524
2014
Q2 		– Sell
-19
Closed -$69K – 670
2014
Q1 		$69K Sell
19
-26
-58% -$96.3K 0.01% 628
2013
Q4 		$147K Buy
45
+3
+7% +$11.8K 0.03% 525
2013
Q3 		$175K Buy
42
+21
+100% +$84.5K 0.04% 463
2013
Q2 		$70K Buy
+21
New +$79.9K 0.02% 406

Other funds holding GYRE

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Spark Investment Management's GYRE Position: Q3 2019 in Review

Spark Investment Management sold out of Gyre Therapeutics (GYRE) in Q3 2019, closing a stake of 1,707 shares — an estimated $94K sold.

Spark Investment Management first reported a position in GYRE in Q2 2013 and held it in 14 quarters. The position peaked at $457K in Q2 2018. 42 funds tracked by Wall St. Rank hold GYRE as of Q3 2019.

  • Spark Investment Management reported no remaining Gyre Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Spark Investment Management sold 1,707 Gyre Therapeutics shares in Q3 2019, an estimated $94K.
  • Spark Investment Management first reported a position in Gyre Therapeutics in Q2 2013 and held it in 14 quarters.
  • Spark Investment Management's Gyre Therapeutics position peaked at $457K in Q2 2018.
  • 42 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q3 2019.

Based on Spark Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.